Before the commencement of trading on the stock market for that day, UnitedHealth Group Incorporated (NYSE: UNH) released its earnings report, offering investors a glimpse into the company’s -third quarter performance.
The market is focused on the outcome, as profits exceeded expectations but revenues did not align with market forecasts.
The financial results for the third quarter show that the firm generated adjusted income of $7.15 per share, complemented by total revenue of $100.82 billion for the corresponding three-month duration.
The findings outshined the wall street anticipated $6.95 profit per share, yet did not reach the expected $101.14 billion revenue
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Q3 2024 | $7.15 | +9.0% | 100.82 B | +9.2% |
| Historical Earnings Insight | ||||
| Q2 2024 | $6.80 | +10.7% | 98.86 B | +6.4% |
| Q1 2024 | $6.91 | +10.4% | 99.80 B | +8.6% |
| Q4 2023 | $6.16 | +15.4% | 94.43 B | +14.1% |
| Q3 2023 | $6.56 | +13.3% | 92.36 B | +14.2% |
| Q2 2023 | $6.14 | +10.2% | 92.90 B | +15.6% |
| *Growth on year-over-year basis | ||||
The revenues advanced 9.16 percent, at the same time per share profit accelerated 8.99 percent in contrast to the comparable quarter of prior year.
Looking ahead at financial projections The firm has set earnings target for full year 2024 that spans from $27.50 to $27.75 per share. At the same time financial experts on Wall Street predict earnings of $27.66 per share.
| Period | Type | Company Outlook |
Analysts Estimate |
Company Vs.* Analysts |
|---|---|---|---|---|
| FY 2024 | EPS | $27.50~$27.75 | $27.66 | -0.1% |
| *Based on mid-point | ||||
Monday’s trading saw UnitedHealth Group (UNH) shares hit a low of $597.38 and a high of $608.63, with a day volume of 2.45 million shares. The stock closed the regular trading session at $605.40, marking 1.23 percent increase.
